Oncternal Therapeutics Inc
NASDAQ:ONCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oncternal Therapeutics Inc
NASDAQ:ONCT
|
US |
|
Medlab Clinical Ltd
ASX:MDC
|
AU |
|
Virbac SA
PAR:VIRP
|
FR |
|
Funko Inc
NASDAQ:FNKO
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ONCT's stock price target?
Not Available
ONCT doesn't have any price targets made by Wall Street professionals.
What is Oncternal Therapeutics Inc's Revenue forecast?
Projected CAGR
9%
The
compound annual growth rate
of
Oncternal Therapeutics Inc's revenue for the next 3 years is
9%.